Elevated Health vs LaSara Medical Group
Elevated Health has an open FDA warning letter dated September 9, 2025. LaSara Medical Group has none. On compounded tirzepatide injection, Elevated Health costs $240 less a year at standing rates: $359 a month against $379 a month at LaSara Medical Group. It is one of two products the two sell at comparable terms.
The record
Elevated Health / LaSara Medical Group
Elevated Health
5.6/10
LaSara Medical Group
5.3/10
Neither Elevated Health nor LaSara Medical Group pays us. Links to them earn nothing. Scores: Elevated Health 5.6, LaSara Medical Group 5.3. How we are paid
What the record shows
- 01
Elevated Health has an open FDA warning letter dated September 9, 2025. LaSara Medical Group has none.
- 02
Neither names the pharmacy that compounds its medication.
- 03
On compounded tirzepatide injection, Elevated Health costs $240 less a year at standing rates: $359 a month against $379 a month at LaSara Medical Group. It is one of two products the two sell at comparable terms.
- 04
Only Elevated Health lists a price for brand-name semaglutide pen.
- 05
Elevated Health lists all 50 states. LaSara Medical Group publishes no state list.
- 06
Elevated Health states you can cancel at any time; LaSara Medical Group does not state its cancellation terms.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Elevated Health
LaSara Medical Group
$296/mo
$3,552 a year
$289/moLower
$3,468 a year
$359/moLower
$4,308 a year
$379/mo
$4,548 a year
$1,399/mo
$16,788 a year
Read off each seller’s own pages. Elevated Health: October 17, 2026. LaSara Medical Group: October 17, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Elevated Health
5.6/10- $240 a year less on compounded tirzepatide injection
- Sells brand-name semaglutide pen, which LaSara Medical Group does not price
- States you can cancel at any time
- Open FDA warning letter, September 9, 2025
- Names no compounding pharmacy
The case for LaSara Medical Group
5.3/10- No FDA warning letter on record
- $84 a year less on compounded semaglutide injection
- Names no compounding pharmacy
- Publishes no state list
Scores
Elevated Health 5.6 · LaSara Medical Group 5.3 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Elevated Health vs LaSara Medical Group: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- bmiMD8.2
From $129/mo prepaid
Visit site - RxSpan MD7.9
From $249/mo
Visit site - Luvo Health7.7
From $179/mo
Visit site
Sellers closest to these two
- Elevated Health vs TrimRx
- Elevated Health vs Trimrose
- Elevated Health vs Fridays
- Elevated Health vs RxSpan MD
- LaSara Medical Group vs Zealthy
- LaSara Medical Group vs Lumora
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks